These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8877679)

  • 1. Predominance of slow acetylators of N-acetyltransferase in a Hmong population residing in the United States.
    Straka RJ; Hansen SR; Benson SR; Walker PF
    J Clin Pharmacol; 1996 Aug; 36(8):740-7. PubMed ID: 8877679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verified predominance of slow acetylator phenotype N-acetyltransferase 2 (NAT2) in a Hmong population residing in Minnesota.
    Straka RJ; Burkhardt RT; Lang NP; Vang T; Hadsall KZ; Tsai MY
    Biopharm Drug Dispos; 2006 Sep; 27(6):299-304. PubMed ID: 16799928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance between N-acetyltransferase 2 phenotype and genotype in a population of Hmong subjects.
    Straka RJ; Burkhardt RT; Lang NP; Hadsall KZ; Tsai MY
    J Clin Pharmacol; 2006 Jul; 46(7):802-11. PubMed ID: 16809806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation phenotypes and biological variation in a French Caucasian population.
    Pontes ZB; Vincent-Viry M; Gueguen R; Galteau MM; Siest G
    Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):59-68. PubMed ID: 8467011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population and family study of N-acetyltransferase using caffeine urinary metabolites.
    Bechtel YC; Bonaiti-Pellie C; Poisson N; Magnette J; Bechtel PR
    Clin Pharmacol Ther; 1993 Aug; 54(2):134-41. PubMed ID: 8354022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylation polymorphism of caffeine in a Japanese population.
    Hashiguchi M; Ebihara A
    Clin Pharmacol Ther; 1992 Sep; 52(3):274-6. PubMed ID: 1526084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe.
    Asprodini EK; Zifa E; Papageorgiou I; Benakis A
    Eur J Drug Metab Pharmacokinet; 1998; 23(4):501-6. PubMed ID: 10323334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine acetylator phenotyping during maturation in infants.
    Pariente-Khayat A; Pons G; Rey E; Richard MO; D'Athis P; Moran C; Badoual J; Olive G
    Pediatr Res; 1991 May; 29(5):492-5. PubMed ID: 1896253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
    Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
    Lu JF; Yi T; Cao XM; Zhuo HT; Ling SS
    Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
    Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
    Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.
    Nyéki A; Buclin T; Biollaz J; Decosterd LA
    Br J Clin Pharmacol; 2003 Jan; 55(1):62-7. PubMed ID: 12534641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine as a potential indicator for acetylator status.
    Rankin RB; Hudson SA; Fell AF
    J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.
    Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E
    J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay.
    Rihs HP; John A; Scherenberg M; Seidel A; Brüning T
    Clin Chim Acta; 2007 Feb; 376(1-2):240-3. PubMed ID: 17011540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
    Fuchs P; Haefeli WE; Ledermann HR; Wenk M
    Eur J Clin Pharmacol; 1999 Jan; 54(11):869-76. PubMed ID: 10027663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.
    Jetter A; Kinzig-Schippers M; Illauer M; Hermann R; Erb K; Borlak J; Wolf H; Smith G; Cascorbi I; Sörgel F; Fuhr U
    Eur J Clin Pharmacol; 2004 Mar; 60(1):17-21. PubMed ID: 14747882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the severity of alcoholic liver cirrhosis and the metabolism of caffeine in 226 patients.
    Bechtel YC; Haffen E; Lelouët H; Brientini MP; Paintaud G; Miguet JP; Bechtel PR
    Int J Clin Pharmacol Ther; 2000 Oct; 38(10):467-75. PubMed ID: 11073287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
    Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.